EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S Smolen
,
Robert Landewé
,
J. W. J. Bijlsma
,
Josef S Smolen
,
Robert Landewé
,
J. W. J. Bijlsma
,
Gerd R Burmester
,
Maxime Dougados
,
Andreas Kerschbaumer
,
Iain B. McInnes
,
Alexandre Sepriano
,
Ronald van Vollenhoven
,
Maarten de Wit
,
Daniel Aletaha
,
Martin Aringer
,
Johan Askling
,
Alejandro Balsa
,
Maarten Boers
,
Alfons A den Broeder
,
Maya H Buch
,
Frank Buttgereit
,
Roberto Caporali
,
Myrna Cardiel
,
Diederik De Cock
,
Cătălin Codreanu
,
Maurizio Cutolo
,
Christopher J Edwards
,
Yvonne van Eijk‐Hustings
,
Paul Emery
,
Axel Finckh
,
Laure Gossec
,
Jacques‐Eric Gottenberg
,
Merete Lund Hetland
,
T. Huizinga
,
Marios Koloumas
,
Zhanguo Li
,
Xavier Mariette
,
Ulf Müller‐Ladner
,
Eduardo Mysler
,
José António Pereira da Silva
,
Gyula Poór
,
Janet Pope
,
Andrea Rubbert‐Roth
,
Adeline Ruyssen‐Witrand
,
Kenneth G. Saag
,
Anja Strangfeld
,
Tsutomu Takeuchi
,
Marieke Voshaar
,
René Westhovens
,
Désirée van der Heijde
2020
Annals of the Rheumatic Diseases
2,587 citations